Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Endocrine

27.04.2024 | Original Article

Identification of potential targetable genes in papillary, follicular, and anaplastic thyroid carcinoma using bioinformatics analysis

verfasst von: Shipra Agarwal, Shikha Gupta, Rishav Raj

Erschienen in: Endocrine

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To perform an extensive exploratory analysis to build a deeper insight into clinically relevant molecular biomarkers in Papillary, Follicular, and Anaplastic thyroid carcinomas (PTC, FTC, ATC).

Methods

Thirteen Thyroid Cancer (THCA) datasets incorporating PTC, FTC, and ATC were derived from the Gene Expression Omnibus. Genes differentially expressed (DEGs) between THCA and normal were identified and subjected to GO and KEGG analyses. Multiple topological properties were harnessed and protein-protein interaction (PPI) networks were constructed to identify the hub genes followed by survival analysis and validation.

Results

There were 70, 87, and 377 DEGs, and 23, 27, and 53 hub genes for PTC, FTC, and ATC samples, respectively. Survival analysis detected 39 overall and 49 relapse-free survival-relevant hub genes. Six hub genes, BCL2, FN1, ITPR1, LYVE1, NTRK2, TBC1D4, were found common to more than one THCA type. The most significant hub genes found in the study were: BCL2, CD44, DCN, FN1, IRS1, ITPR1, MFAP4, MKI67, NTRK2, PCLO, TGFA. The most enriched and significant GO terms were Melanocyte differentiation for PTC, Extracellular region for FTC, and Extracellular exosome for ATC. Prostate cancer for PTC was the most significantly enriched KEGG pathway. The results were validated using TCGA data.

Conclusions

The findings unravel potential biomarkers and therapeutic targets of thyroid carcinomas.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
C.C. Juhlin, O. Mete, Z.W. Baloch, The 2022 who classification of thyroid tumors: novel concepts in nomenclature and grading. Endocrine-Related Cancer 30, e220293 (2023).
2.
S. Wang, J. Wu, C. Guo et al. Identification and validation of novel genes in anaplastic thyroid carcinoma via bioinformatics analysis. Cancer Manag. Res. 9787–9799 (2020)
3.
Y. Shen, S. Dong, J. Liu et al. Identification of potential biomarkers for thyroid cancer using bioinformatics strategy: a study based on geo datasets. BioMed. Res. Int. 2020 (2020)
4.
L. Liu, C. He, Q. Zhou et al. Identification of key genes and pathways of thyroid cancer by integrated bioinformatics analysis. J. Cellular Physiol. 234, 23647–23657 (2019)CrossRef
5.
J. Tang, D. Kong, Q. Cui et al. Bioinformatic analysis and identification of potential prognostic micrornas and mrnas in thyroid cancer. PeerJ 6, e4674 (2018)PubMedCrossRefPubMedCentral
6.
R. Edgar, M. Domrachev, A.E. Lash, Gene expression omnibus: Ncbi gene expression and hybridization array data repository. Nucleic Acids Res. 30, 207–210 (2002)PubMedCrossRefPubMedCentral
7.
8.
A. Franceschini, D. Szklarczyk, S. Frankild et al. String v9. 1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 41, D808–D815 (2012)PubMedCrossRefPubMedCentral
9.
P. Shannon, A. Markiel, O. Ozier et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498–2504 (2003)PubMedCrossRefPubMedCentral
10.
C.-H. Chin, S.H. Chen, H.H. Wu et al. cytohubba: identifying hub objects and sub-networks from complex interactome. BMC Syst. Biol. 8, 1–7 (2014)CrossRef
11.
B.T. Sherman, M. Hao, J. Qiu et al. David: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 50, W216–W221 (2022)PubMedCrossRefPubMedCentral
12.
13.
14.
N. Agrawal, R. Akbani, B.A. Aksoy et al. Integrated genomic characterization of papillary thyroid carcinoma. Cell 159, 676–690 (2014)CrossRefPubMedCentral
15.
Á. Bartha, B. Győrffy, Tnmplot. com: a web tool for the comparison of gene expression in normal, tumor and metastatic tissues. Int. J. Mol. Sci. 22, 2622 (2021)PubMedCrossRefPubMedCentral
16.
T. Knight, D. Luedtke, H. Edwards et al. A delicate balance–the bcl-2 family and its role in apoptosis, oncogenesis, and cancer therapeutics. Biochem. Pharmacol. 162, 250–261 (2019)PubMedCrossRef
17.
V.K. Anagnostou, F.J. Lowery, V. Zolota et al. High expression of bcl-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology. BMC Cancer 10, 1–11 (2010)CrossRef
18.
S. Wu, F. Wu, Z. Jiang, Identification of hub genes, key mirnas and potential molecular mechanisms of colorectal cancer. Oncol. Rep. 38, 2043–2050 (2017)PubMedCrossRefPubMedCentral
19.
W. Liang, F. Sun, Identification of key genes of papillary thyroid cancer using integrated bioinformatics analysis. J. Endocrinol. Investig. 41, 1237–1245 (2018)CrossRef
20.
Y. Liu, S. Gao, Y. Jin et al. Bioinformatics analysis to screen key genes in papillary thyroid carcinoma. Oncol. Lett. 19, 195–204 (2020)PubMed
21.
X. Li, J. He, M. Zhou et al. Identification and validation of core genes involved in the development of papillary thyroid carcinoma via bioinformatics analysis. Int. J. Genomics 2019 (2019).
22.
A. Almansoori, P. M. Bhamidimarri, R. Bendardaf et al. Identifying diagnostic and prognostic targets for papillary thyroid carcinoma through mining gene expression big datasets using adaptive filtering and advanced bioinformatics algorithms. In 2021 14th International Conference on Developments in eSystems Engineering (DeSE), 358–363 (IEEE, 2021).
23.
Y.-X. Wang, L. Zhao, X.-Y. Wang et al. Role of caspase 8, caspase 9 and bcl-2 polymorphisms in papillary thyroid carcinoma risk in Han Chinese population. Med. Oncol. 29, 2445–2451 (2012)PubMedCrossRef
24.
25.
K. Xie, A biomarker and molecular mechanism investigation for thyroid cancer. Central Eur. J. Immunol. 48, 203–218 (2023)CrossRef
26.
H.-N. Li, H.M. Zhang, X.R. Li et al. Mir-205-5p/ggct attenuates growth and metastasis of papillary thyroid cancer by regulating cd44. Endocrinology 163, bqac022 (2022)PubMedCrossRefPubMedCentral
27.
T. Kawai, K. Iwata, Y. Shinotsuka et al. Cd44v8-10 and cd44s are age-dependently expressed in primary cultured papillary thyroid carcinoma cells and are associated with cell proliferation. Kobe J. Med. Sci. 65, E1 (2019)PubMedPubMedCentral
28.
T. Okada, T. Nakamura, T. Watanabe et al. Coexpression of epcam, cd44 variant isoforms and claudin-7 in anaplastic thyroid carcinoma. PLoS One 9, e94487 (2014)PubMedCrossRefPubMedCentral
29.
Z. Wang, Q. Wang, Q. Wang et al. Prognostic significance of cd24 and cd44 in breast cancer: a meta-analysis. Int. J. Biol. Mark. 32, 75–82 (2017)CrossRef
30.
S. Goldoni, R.V. Iozzo, Tumor microenvironment: modulation by decorin and related molecules harboring leucine-rich tandem motifs. Int. J. Cancer 123, 2473–2479 (2008)PubMedCrossRef
31.
L. Arnaldi, R. Borra, R. Maciel et al. Gene expression profiles reveal that dcn, dio1, and dio2 are underexpressed in benign and malignant thyroid tumors. Thyroid 15, 210–221 (2005)PubMedCrossRef
32.
Y. Wan, X. Zhang, H. Leng et al. Identifying hub genes of papillary thyroid carcinoma in the tcga and geo database using bioinformatics analysis. PeerJ 8, e9120 (2020)PubMedCrossRefPubMedCentral
33.
R.I. Lieverse, D. Marcus, A.M. van der Wiel et al. Human fibronectin extra domain b as a biomarker for targeted therapy in cancer. Mol. Oncol. 14, 1555–1568 (2020)PubMedCrossRefPubMedCentral
34.
T. Qu, Y.-P. Li, X.-H. Li et al. Identification of potential biomarkers and drugs for papillary thyroid cancer based on gene expression profile analysis. Mol. Med. Rep. 14, 5041–5048 (2016)PubMedCrossRefPubMedCentral
35.
Q.-S. Geng, T. Huang, L.F. Li et al. Over-expression and prognostic significance of fn1, correlating with immune infiltrates in thyroid cancer. Front. Med. 8, 812278 (2022)CrossRef
36.
J. Han, M. Chen, Y. Wang et al. Identification of biomarkers based on differentially expressed genes in papillary thyroid carcinoma. Sci. Rep. 8, 9912 (2018)PubMedCrossRefPubMedCentral
37.
G. Xue, X. Lin, J.F. Wu et al. Identification of key genes of papillary thyroid carcinoma by integrated bioinformatics analysis. Biosci. Rep. 40, BSR20201555 (2020)PubMedCrossRefPubMedCentral
38.
R. Fan, L. Dong, P. Li et al. Integrated bioinformatics analysis and screening of hub genes in papillary thyroid carcinoma. Plos One 16, e0251962 (2021)PubMedCrossRefPubMedCentral
39.
Z. Li, C. Xiong, J. Wei et al. Identification of potential key genes in anaplastic thyroid cancer using bioinformatics analysis. Blood&Genomics 6, 53–61 (2022)CrossRef
40.
J. Wang, L. Wu, W. Lu et al. Identification of key pathways and genes downstream of insulin-like growth factor 1 in thyroid carcinoma. Genetic Testing Mol. Biomarkers 26, 522–531 (2022)CrossRef
41.
F. Yu, D. Huang, Y. Kuang, et al. Irs1 promotes thyroid cancer metastasis through emt and pi3k/akt pathways. Clin. Endocrinol. 100, 284–293 (2024). CrossRef
42.
Q. Xu, A. Song, Q. Xie, The integrated analyses of driver genes identify key biomarkers in thyroid cancer. Technol. Cancer Res. Treat. 19, 1533033820940440 (2020)PubMedCrossRefPubMedCentral
43.
G. Hu, H.-f Feng, H. Zhan, Identification of an autophagy-related signature predicting overall survival for papillary thyroid carcinoma. Dose-Response 18, 1559325819899265 (2020)PubMedCrossRefPubMedCentral
44.
D. Peng, W. Li, B. Zhang et al. Overexpression of lncrna slc26a4-as1 inhibits papillary thyroid carcinoma progression through recruiting ets1 to promote itpr1-mediated autophagy. J. Cell. Mol. Med. 25, 8148–8158 (2021)PubMedCrossRefPubMedCentral
45.
Y. Hu, N. Zhou, R. Wang, Apatinib strengthens the anti-tumor effect of cisplatin in thyroid carcinoma through downregulating vegfr2. J BUON 26, 613–9 (2021)PubMed
46.
M.-L. Tsai, C.H. Lee, L.C. Huang et al. Crispr-mediated knockout of vegfr2/kdr inhibits cell growth in a squamous thyroid cancer cell line. FEBS Open Bio. 12, 993–1005 (2022)PubMedCrossRefPubMedCentral
47.
M. Wu, H. Yuan, X. Li et al. Identification of a five-gene signature and establishment of a prognostic nomogram to predict progression-free interval of papillary thyroid carcinoma. Front. Endocrinol. 10, 790 (2019)CrossRef
48.
L.K. Dalkilic, S. Dalkilic, Identification of key genes involved in papillary thyroid cancer by bioinformatics tools. Progr. Nutr. 33, e2020014 (2020).
49.
H.S. Kim, D.H. Kim, J.Y. Kim et al. Microarray analysis of papillary thyroid cancers in korean. Kor. J. Internal Med. 25, 399 (2010)CrossRef
50.
J. Li, J. Wang, Z. Liu et al. Tumor-suppressive role of microfibrillar associated protein 4 and its clinical significance as prognostic factor and diagnostic biomarker in hepatocellular carcinoma. J. Cancer Res. Ther. 18, 1919–1925 (2022)PubMedCrossRef
51.
R. Yerushalmi, R. Woods, P.M. Ravdin et al. Ki67 in breast cancer: prognostic and predictive potential. The Lancet Oncol. 11, 174–183 (2010)PubMedCrossRef
52.
53.
Y. Han, K. Xia, T. Su, Exploration of the important role of microfibril-associated protein 4 gene in oral squamous cell carcinoma. Med. Sci. Monit.: Int. Med. J. Exp. Clin. Res. 27, e931238–1 (2021)CrossRef
54.
55.
L. Shi, Y. Huang, X. Huang et al. Analyzing the key gene expression and prognostics values for acute myeloid leukemia. Transl. Cancer Res. 9, 7284 (2020)PubMedCrossRefPubMedCentral
56.
Y. Zhang, Z. Qiu, L. Wei et al. Integrated analysis of mutation data from various sources identifies key genes and signaling pathways in hepatocellular carcinoma. PloS One 9, e100854 (2014)PubMedCrossRefPubMedCentral
57.
M. Bernhardt, H.-M. Behrens, S. Krüger et al. Exploration of the tumor biological significance of pclo in gastric cancer-results from a large central european cohort. Pathobiol. J. Immunopathol. Mol. Cellular Biol. 1–9 (2023) (Online ahead of print).
58.
R. Sun, Y. Yang, W. Lü et al. Single-cell transcriptomic analysis of normal and pathological tissues from the same patient uncovers colon cancer progression. Cell Biosci. 13, 1–15 (2023)CrossRef
59.
O.L. Griffith, A. Melck, S.J. Jones et al. Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers. J. Clin. Oncol. 24, 5043–5051 (2006)PubMedCrossRef
60.
D. Degl’Innocenti, C. Alberti, G. Castellano et al. Integrated ligand-receptor bioinformatic and in vitro functional analysis identifies active tgfa/egfr signaling loop in papillary thyroid carcinomas. PLoS One 5, e12701 (2010)PubMedCrossRefPubMedCentral
61.
E. Molinaro, C. Romei, A. Biagini et al. Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies. Nat. Rev. Endocrinol. 13, 644–660 (2017)PubMedCrossRef
Metadaten
Titel
Identification of potential targetable genes in papillary, follicular, and anaplastic thyroid carcinoma using bioinformatics analysis
verfasst von
Shipra Agarwal
Shikha Gupta
Rishav Raj
Publikationsdatum
27.04.2024
Verlag
Springer US
Erschienen in
Endocrine
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-024-03836-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise